1. ZhuJ, PaulWE (2010) Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 238: 247–262.
2. JoffreO, NolteMA, SporriR, Reis e SousaC (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227: 234–247.
3. MosmannTR, CherwinskiH, BondMW, GiedlinMA, CoffmanRL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357.
4. OkoyeIS, WilsonMS (2011) CD4+ T helper 2 cells–microbial triggers, differentiation requirements and effector functions. Immunology 134: 368–377.
5. RoweJH, ErteltJM, WaySS (2012) Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology 136: 1–10.
6. TakedaA, HamanoS, YamanakaA, HanadaT, IshibashiT, et al. (2003) Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170: 4886–4890.
7. LighvaniAA, FruchtDM, JankovicD, YamaneH, AlibertiJ, et al. (2001) T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 98: 15137–15142.
8. HibbertL, PflanzS, De Waal MalefytR, KasteleinRA (2003) IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23: 513–522.
9. KamiyaS, OwakiT, MorishimaN, FukaiF, MizuguchiJ, et al. (2004) An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol 173: 3871–3877.
10. LucasS, GhilardiN, LiJ, de SauvageFJ (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100: 15047–15052.
11. AfkarianM, SedyJR, YangJ, JacobsonNG, CerebN, et al. (2002) T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 3: 549–557.
12. SzaboSJ, SullivanBM, StemmannC, SatoskarAR, SleckmanBP, et al. (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295: 338–342.
13. ThierfelderWE, van DeursenJM, YamamotoK, TrippRA, SarawarSR, et al. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171–174.
14. KaplanMH, SunYL, HoeyT, GrusbyMJ (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174–177.
15. SzaboSJ, KimST, CostaGL, ZhangX, FathmanCG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655–669.
16. LordGM, RaoRM, ChoeH, SullivanBM, LichtmanAH, et al. (2005) T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106: 3432–3439.
17. GroomJR, LusterAD (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207–215.
18. HsiehCS, MacatoniaSE, TrippCS, WolfSF, O'GarraA, et al. (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547–549.
19. KempM, KurtzhalsJA, BendtzenK, PoulsenLK, HansenMB, et al. (1993) Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 61: 1069–1073.
20. SwainSL, McKinstryKK, StruttTM (2012) Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 12: 136–148.
21. MutisT, CornelisseYE, OttenhoffTH (1993) Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol 23: 2189–2195.
22. HaanenJB, de Waal MalefijtR, ResPC, KraakmanEM, OttenhoffTH, et al. (1991) Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 174: 583–592.
23. ZhangM, GatelyMK, WangE, GongJ, WolfSF, et al. (1994) Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 93: 1733–1739.
24. de JongR, AltareF, HaagenIA, ElferinkDG, BoerT, et al. (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435–1438.
25. AltareF, DurandyA, LammasD, EmileJF, LamhamediS, et al. (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432–1435.
26. FrohlichA, KisielowJ, SchmitzI, FreigangS, ShamshievAT, et al. (2009) IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324: 1576–1580.
27. YiJS, DuM, ZajacAJ (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science 324: 1572–1576.
28. YiJS, IngramJT, ZajacAJ (2010) IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J Immunol 185: 4835–4845.
29. SwainSL, WeinbergAD, EnglishM, HustonG (1990) IL-4 directs the development of Th2-like helper effectors. J Immunol 145: 3796–3806.
30. Le GrosG, Ben-SassonSZ, SederR, FinkelmanFD, PaulWE (1990) Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 172: 921–929.
31. KaplanMH, SchindlerU, SmileyST, GrusbyMJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313–319.
32. ShimodaK, van DeursenJ, SangsterMY, SarawarSR, CarsonRT, et al. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630–633.
33. TakedaK, TanakaT, ShiW, MatsumotoM, MinamiM, et al. (1996) Essential role of Stat6 in IL-4 signalling. Nature 380: 627–630.
34. ZhuJ, GuoL, WatsonCJ, Hu-LiJ, PaulWE (2001) Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 166: 7276–7281.
35. ZhengW, FlavellRA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587–596.
36. ZhangDH, CohnL, RayP, BottomlyK, RayA (1997) Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 272: 21597–21603.
37. OuyangW, LohningM, GaoZ, AssenmacherM, RanganathS, et al. (2000) Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12: 27–37.
38. PaulWE (2010) What determines Th2 differentiation, in vitro and in vivo? Immunol Cell Biol 88: 236–239.
39. MikhakZ, FukuiM, FarsidjaniA, MedoffBD, TagerAM, et al. (2009) Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. J Allergy Clin Immunol 123: 67–e63, 67-73, e63.
40. SallustoF, MackayCR, LanzavecchiaA (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005–2007.
41. PearceEJ, CasparP, GrzychJM, LewisFA, SherA (1991) Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 173: 159–166.
42. ElseKJ, HultnerL, GrencisRK (1992) Cellular immune responses to the murine nematode parasite Trichuris muris. II. Differential induction of TH-cell subsets in resistant versus susceptible mice. Immunology 75: 232–237.
43. SchrammG, HaasH (2010) Th2 immune response against Schistosoma mansoni infection. Microbes Infect 12: 881–888.
44. MaizelsRM, HewitsonJP, SmithKA (2012) Susceptibility and immunity to helminth parasites. Curr Opin Immunol 24: 459–466.
45. HarringtonLE, HattonRD, ManganPR, TurnerH, MurphyTL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123–1132.
46. ParkH, LiZ, YangXO, ChangSH, NurievaR, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133–1141.
47. GalloE, KatzmanS, VillarinoAV (2012) IL-13-producing Th1 and Th17 cells characterize adaptive responses to both self and foreign antigens. Eur J Immunol 42: 2322–2328.
48. RaymondM, VanVQ, WakaharaK, RubioM, SarfatiM (2011) Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. J Allergy Clin Immunol 128: 192–e196, 192-201, e196.
49. BonifaceK, BlumenscheinWM, Brovont-PorthK, McGeachyMJ, BashamB, et al. (2010) Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. J Immunol 185: 679–687.
50. ZielinskiCE, MeleF, AschenbrennerD, JarrossayD, RonchiF, et al. (2012) Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484: 514–518.
51. VeldhoenM, HockingRJ, AtkinsCJ, LocksleyRM, StockingerB (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179–189.
52. ManganPR, HarringtonLE, O'QuinnDB, HelmsWS, BullardDC, et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234.
53. ZhouL, IvanovII, SpolskiR, MinR, ShenderovK, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967–974.
54. YangXO, PanopoulosAD, NurievaR, ChangSH, WangD, et al. (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282: 9358–9363.
55. HarrisTJ, GrossoJF, YenHR, XinH, KortylewskiM, et al. (2007) Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179: 4313–4317.
56. IvanovII, McKenzieBS, ZhouL, TadokoroCE, LepelleyA, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121–1133.
57. YangXO, PappuBP, NurievaR, AkimzhanovA, KangHS, et al. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28: 29–39.
58. WeiL, LaurenceA, EliasKM, O'SheaJJ (2007) IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 282: 34605–34610.
59. NurievaR, YangXO, MartinezG, ZhangY, PanopoulosAD, et al. (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480–483.
60. GutcherI, DonkorMK, MaQ, RudenskyAY, FlavellRA, et al. (2011) Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity 34: 396–408.
61. GhoreschiK, LaurenceA, YangXP, TatoCM, McGeachyMJ, et al. (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467: 967–971.
62. LeeY, AwasthiA, YosefN, QuintanaFJ, XiaoS, et al. (2012) Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13: 991–999.
63. YamazakiT, YangXO, ChungY, FukunagaA, NurievaR, et al. (2008) CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 181: 8391–8401.
64. YuJJ, GaffenSL (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13: 170–177.
65. LockhartE, GreenAM, FlynnJL (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177: 4662–4669.
66. TakatoriH, KannoY, WatfordWT, TatoCM, WeissG, et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206: 35–41.
67. GladiatorA, WanglerN, Trautwein-WeidnerK, LeibundGut-LandmannS (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190: 521–525.
68. DoisneJM, SoulardV, BecourtC, AmniaiL, HenrotP, et al. (2011) Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol 186: 662–666.
69. CuaDJ, TatoCM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479–489.
70. RubinoSJ, GeddesK, GirardinSE (2012) Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 33: 112–118.
71. YeP, GarveyPB, ZhangP, NelsonS, BagbyG, et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25: 335–340.
72. HappelKI, DubinPJ, ZhengM, GhilardiN, LockhartC, et al. (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202: 761–769.
73. WangF, XuJ, LiaoY, WangY, LiuC, et al. (2011) Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection. Cell Immunol 269: 22–28.
74. IshigameH, KakutaS, NagaiT, KadokiM, NambuA, et al. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108–119.
75. IvanovII, AtarashiK, ManelN, BrodieEL, ShimaT, et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485–498.
76. HigginsSC, JarnickiAG, LavelleEC, MillsKH (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177: 7980–7989.
77. AndreasenC, PowellDA, CarbonettiNH (2009) Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS ONE 4: e7079.
78. YuJJ, RuddyMJ, WongGC, SfintescuC, BakerPJ, et al. (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794–3802.
79. YuJJ, RuddyMJ, ContiHR, BoonanantanasarnK, GaffenSL (2008) The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun 76: 4206–4213.
80. LuY-J, GrossJ, BogaertD, FinnA, BagradeL, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
81. ZhangZ, ClarkeTB, WeiserJN (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899–1909.
82. McGeachyMJ, ChenY, TatoCM, LaurenceA, Joyce-ShaikhB, et al. (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10: 314–324.
83. GeddesK, RubinoSJ, MagalhaesJG, StreutkerC, Le BourhisL, et al. (2011) Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17: 837–844.
84. BuonocoreS, AhernPP, UhligHH, IvanovII, LittmanDR, et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371–1375.
85. PriceAE, ReinhardtRL, LiangH-E, LocksleyRM (2012) Marking and quantifying IL-17A-producing cells in vivo. PLoS ONE 7: e39750.
86. SuttonCE, MielkeLA, MillsKH (2012) IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol 42: 2221–2231.
87. Hernandez-SantosN, GaffenSL (2012) Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425–435.
88. Acosta-RodriguezEV, RivinoL, GeginatJ, JarrossayD, GattornoM, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639–646.
89. EyerichK, FoersterS, RomboldS, SeidlHP, BehrendtH, et al. (2008) Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128: 2640–2645.
90. MilnerJD, BrenchleyJM, LaurenceA, FreemanAF, HillBJ, et al. (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773–776.
91. MaCS, ChewGY, SimpsonN, PriyadarshiA, WongM, et al. (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205: 1551–1557.
92. MinegishiY, SaitoM, TsuchiyaS, TsugeI, TakadaH, et al. (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058–1062.
93. GrimbacherB, HollandSM, GallinJI, GreenbergF, HillSC, et al. (1999) Hyper-IgE syndrome with recurrent infections–an autosomal dominant multisystem disorder. N Engl J Med 340: 692–702.
94. HuangW, NaL, FidelPL, SchwarzenbergerP (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624–631.
95. FarahCS, HuY, RimintonS, AshmanRB (2006) Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol Immunol 21: 252–255.
96. ContiHR, ShenF, NayyarN, StocumE, SunJN, et al. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299–311.
97. HoAW, ShenF, ContiHR, PatelN, ChildsEE, et al. (2010) IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol 185: 1063–1070.
98. KagamiS, RizzoHL, KurtzSE, MillerLS, BlauveltA (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185: 5453–5462.
99. AntachopoulosC, WalshTJ (2012) Immunotherapy of Cryptococcus infections. Clin Microbiol Infect 18: 126–133.
100. ZelanteT, BozzaS, De LucaA, D'AngeloC, BonifaziP, et al. (2009) Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 47 Suppl 1: S162–169.
101. RudnerXL, HappelKI, YoungEA, ShellitoJE (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75: 3055–3061.
102. Hernandez-SantosN, HupplerAR, PetersonAC, KhaderSA, McKennaKC, et al. (2013) Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol 6: 900–910.
103. ChenK, McAleerJP, LinY, PatersonDL, ZhengM, et al. (2011) Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35: 997–1009.
104. WuthrichM, GernB, HungCY, ErslandK, RoccoN, et al. (2011) Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 121: 554–568.
105. KumarP, ChenK, KollsJK (2013) Th17 cell based vaccines in mucosal immunity. Curr Opin Immunol 25: 373–380.
106. KhaderSA, GopalR (2010) IL-17 in protective immunity to intracellular pathogens. Virulence 1: 423–427.
107. WoolardMD, HensleyLL, KawulaTH, FrelingerJA (2008) Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun 76: 2651–2659.
108. LinY, RitcheaS, LogarA, SlightS, MessmerM, et al. (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799–810.
109. BaiH, ChengJ, GaoX, JoyeeAG, FanY, et al. (2009) IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 183: 5886–5895.
110. UmemuraM, YahagiA, HamadaS, BegumMD, WatanabeH, et al. (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178: 3786–3796.
111. WuQ, MartinRJ, RinoJG, BreedR, TorresRM, et al. (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9: 78–86.
112. GodinezI, RaffatelluM, ChuH, PaixaoTA, HanedaT, et al. (2009) Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect Immun 77: 387–398.
113. RaffatelluM, SantosRL, VerhoevenDE, GeorgeMD, WilsonRP, et al. (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14: 421–428.
114. SuryawanshiA, Veiga-PargaT, RajasagiNK, ReddyPB, SehrawatS, et al. (2011) Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol 187: 1919–1930.
115. HouW, KangHS, KimBS (2009) Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 206: 313–328.
116. OyoshiMK, ElkhalA, KumarL, ScottJE, KoduruS, et al. (2009) Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A 106: 14954–14959.
117. McKinstryKK, StruttTM, BuckA, CurtisJD, DibbleJP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353–7363.
118. KellyMN, KollsJK, HappelK, SchwartzmanJD, SchwarzenbergerP, et al. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73: 617–621.
119. TallimaH, SalahM, GuirguisFR, El RidiR (2009) Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine 48: 239–245.
120. RutitzkyLI, Lopes da RosaJR, StadeckerMJ (2005) Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 175: 3920–3926.
121. RutitzkyLI, StadeckerMJ (2006) CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem Inst Oswaldo Cruz 101 Suppl 1: 327–330.
122. MoffittKL, GierahnTM, LuY-J, GouveiaP, AldersonM, et al. (2011) T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9: 158–165.
123. DuhenT, GeigerR, JarrossayD, LanzavecchiaA, SallustoF (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857–863.
124. TrifariS, KaplanCD, TranEH, CrellinNK, SpitsH (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864–871.
125. SonnenbergGF, FouserLA, ArtisD (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383–390.
126. RamirezJ-M, BrembillaNC, SorgO, ChicheporticheR, MatthesT, et al. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40: 2450–2459.
127. BrembillaNC, RamirezJ-M, ChicheporticheR, SorgO, SauratJ-H, et al. (2011) In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner. PLoS ONE 6: e18741.
128. TachiiriA, ImamuraR, WangY, FukuiM, UmemuraM, et al. (2003) Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun 4: 153–159.
129. WolkK, KunzS, WitteE, FriedrichM, AsadullahK, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241–254.
130. LiangSC, TanXY, LuxenbergDP, KarimR, Dunussi-JoannopoulosK, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271–2279.
131. WolkK, WitteE, WallaceE, DockeWD, KunzS, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309–1323.
132. ZhengY, ValdezPA, DanilenkoDM, HuY, SaSM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282–289.
133. AujlaSJ, ChanYR, ZhengM, FeiM, AskewDJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275–281.
134. WitteE, WitteK, WarszawskaK, SabatR, WolkK (2010) Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 21: 365–379.
135. LiuY, YangB, ZhouM, LiL, ZhouH, et al. (2009) Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans. Eur J Immunol 39: 1472–1479.
136. NgWF, von DelwigA, CarmichaelAJ, ArkwrightPD, AbinunM, et al. (2010) Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Allergy Clin Immunol 126: 1006–1004, 1006-1015, 1015, e1001-1004.
137. van der MeerJW, van de VeerdonkFL, JoostenLA, KullbergBJ, NeteaMG (2010) Severe Candida spp. infections: new insights into natural immunity. Int J Antimicrob Agents 36 Suppl 2: S58–62.
138. EyerichS, WagenerJ, WenzelV, ScarponiC, PenninoD, et al. (2011) IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 41: 1894–1901.
139. De LucaA, ZelanteT, D'AngeloC, ZagarellaS, FallarinoF, et al. (2010) IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 3: 361–373.
140. WilsonMS, FengCG, BarberDL, YarovinskyF, CheeverAW, et al. (2010) Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 184: 4378–4390.
141. ZenewiczLA, YancopoulosGD, ValenzuelaDM, MurphyAJ, KarowM, et al. (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647–659.
142. GuoH, TophamDJ (2010) Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 84: 7750–7759.
143. MunozM, HeimesaatMM, DankerK, StruckD, LohmannU, et al. (2009) Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 206: 3047–3059.
144. IvanovS, RennesonJ, FontaineJ, BarthelemyA, PagetC, et al. (2013) Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J Virol 87: 6911–6924.
145. PociaskDA, SchellerEV, MandalapuS, McHughKJ, EnelowRI, et al. (2013) IL-22 is essential for lung epithelial repair following influenza infection. Am J Pathol 182: 1286–1296.
146. GuabirabaR, BesnardAG, MarquesRE, MailletI, FagundesCT, et al. (2013) IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection. Eur J Immunol 43: 1529–1544.
147. BehrendsJ, RenauldJ-C, EhlersS, HölscherC (2013) IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. PLoS ONE 8: e57379.
148. ScribaTJ, KalsdorfB, AbrahamsDA, IsaacsF, HofmeisterJ, et al. (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180: 1962–1970.
149. QingK, FengWW, FanY, LiLY, MinXY, et al. (2012) Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis. Virol J 9: 232.
150. BasuR, O'QuinnDB, SilbergerDJ, SchoebTR, FouserL, et al. (2012) Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37: 1061–1075.
151. GoswamiR, KaplanMH (2011) A brief history of IL-9. J Immunol 186: 3283–3288.
152. GessnerA, BlumH, RollinghoffM (1993) Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189: 419–435.
153. FaulknerH, RenauldJ-C, Van SnickJ, GrencisRK (1998) Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect Immun 66: 3832–3840.
154. FaulknerH, HumphreysN, RenauldJ-C, Van SnickJ, GrencisR (1997) Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol 27: 2536–2540.
155. DugasB, RenauldJC, PeneJ, BonnefoyJY, Peti-FrereC, et al. (1993) Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 23: 1687–1692.
156. Petit-FrereC, DugasB, BraquetP, Mencia-HuertaJM (1993) Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 79: 146–151.
157. LiH, RostamiA (2010) IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 5: 198–209.
158. DardalhonV, AwasthiA, KwonH, GalileosG, GaoW, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat Immunol 9: 1347–1355.
159. VeldhoenM, UyttenhoveC, van SnickJ, HelmbyH, WestendorfA, et al. (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341–1346.
160. YangXO, ZhangH, KimBS, NiuX, PengJ, et al. (2013) The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat Immunol 14: 732–740.
161. UyttenhoveC, BrombacherF, Van SnickJ (2010) TGF-beta interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells. Eur J Immunol 40: 2230–2235.
162. SchmittE, KleinM, BoppT (2013) Th9 cells, new players in adaptive immunity. Trends Immunol E-pub ahead of print.
163. PerumalNB, KaplanMH (2011) Regulating Il9 transcription in T helper cells. Trends Immunol 32: 146–150.
164. ChangHC, SehraS, GoswamiR, YaoW, YuQ, et al. (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11: 527–534.
165. StaudtV, BothurE, KleinM, LingnauK, ReuterS, et al. (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192–202.
166. JabeenR, GoswamiR, AweO, KulkarniA, NguyenET, et al. (2013) Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest E-pub ahead of print.
167. KaraEE, ComerfordI, BastowCR, FenixKA, LitchfieldW, et al. (2013) Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. J Immunol 191: 1110–1117.
168. KhanWI, RichardM, AkihoH, BlennerhassetPA, HumphreysNE, et al. (2003) Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect Immun 71: 2430–2438.
169. Licona-LimonP, Henao-MejiaJ, TemannAU, GaglianiN, Licona-LimonI, et al. (2013) Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39: 744–757.
170. TurnerJE, MorrisonPJ, WilhelmC, WilsonM, AhlforsH, et al. (2013) IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210: 2951–2965.
171. TownsendJM, FallonGP, MatthewsJD, SmithP, JolinEH, et al. (2000) IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573–583.
172. LiE, ZhouP, PetrinZ, SingerSM (2004) Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun 72: 6642–6649.
173. FallonPG, JolinHE, SmithP, EmsonCL, TownsendMJ, et al. (2002) IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 17: 7–17.
174. YamasakiA, SalehA, KoussihL, MuroS, HalaykoAJ, et al. (2010) IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS ONE 5: e9178.
175. GounniAS, HamidQ, RahmanSM, HoeckJ, YangJ, et al. (2004) IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J Immunol 173: 2771–2779.
176. LouahedJ, ZhouY, MaloyWL, RaniPU, WeissC, et al. (2001) Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97: 1035–1042.
177. McNamaraPS, FlanaganBF, BaldwinLM, NewlandP, HartCA, et al. (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363: 1031–1037.
178. DoddJS, LumE, GouldingJ, MuirR, Van SnickJ, et al. (2009) IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection. J Immunol 183: 7006–7013.
179. GrohmannU, Van SnickJ, CampanileF, SillaS, GiampietriA, et al. (2000) IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. J Immunol 164: 4197–4203.
180. YeZ-J, YuanM-L, ZhouQ, DuR-H, YangW-B, et al. (2012) Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS ONE 7: e31710.
181. NoelleRJ, NowakEC (2010) Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 10: 683–687.
182. WilhelmC, HirotaK, StieglitzB, Van SnickJ, TolainiM, et al. (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12: 1071–1077.
183. NuttSL, TarlintonDM (2011) Germinal center B and follicular helper T cells: siblings, cousins or just good friends? Nat Immunol 12: 472–477.
184. CrottyS (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29: 621–663.
185. JohnstonRJ, PoholekAC, DiToroD, YusufI, EtoD, et al. (2009) Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325: 1006–1010.
186. NurievaRI, ChungY, MartinezGJ, YangXO, TanakaS, et al. (2009) Bcl6 mediates the development of T follicular helper cells. Science 325: 1001–1005.
187. YuD, RaoS, TsaiLM, LeeSK, HeY, et al. (2009) The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31: 457–468.
188. KingIL, MohrsM (2009) IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J Exp Med 206: 1001–1007.
189. HsuHC, YangP, WangJ, WuQ, MyersR, et al. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166–175.
190. LintermanMA, BeatonL, YuD, RamiscalRR, SrivastavaM, et al. (2010) IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 207: 353–363.
191. LeeSK, SilvaDG, MartinJL, PratamaA, HuX, et al. (2012) Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37: 880–892.
192. ChtanovaT, TangyeSG, NewtonR, FrankN, HodgeMR, et al. (2004) T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173: 68–78.
193. NurievaRI, ChungY, HwangD, YangXO, KangHS, et al. (2008) Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138–149.
194. KimCH, LimHW, KimJR, RottL, HillsamerP, et al. (2004) Unique gene expression program of human germinal center T helper cells. Blood 104: 1952–1960.
195. KroenkeMA, EtoD, LocciM, ChoM, DavidsonT, et al. (2012) Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 188: 3734–3744.
196. BreitfeldD, OhlL, KremmerE, EllwartJ, SallustoF, et al. (2000) Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192: 1545–1552.
197. SchaerliP, WillimannK, LangAB, LippM, LoetscherP, et al. (2000) CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192: 1553–1562.
198. MaCS, DeenickEK, BattenM, TangyeSG (2012) The origins, function, and regulation of T follicular helper cells. J Exp Med 209: 1241–1253.
199. FazilleauN, McHeyzer-WilliamsLJ, RosenH, McHeyzer-WilliamsMG (2009) The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 10: 375–384.
200. DeenickEK, ChanA, MaCS, GattoD, SchwartzbergPL, et al. (2010) Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity 33: 241–253.
201. EtoD, LaoC, DiToroD, BarnettB, EscobarTC, et al. (2011) IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6: e17739.
202. MaCS, AveryDT, ChanA, BattenM, BustamanteJ, et al. (2012) Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119: 3997–4008.
203. ChoiYS, EtoD, YangJA, LaoC, CrottyS (2013) Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol 190: 3049–3053.
204. MaCS, SuryaniS, AveryDT, ChanA, NananR, et al. (2009) Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 87: 590–600.
205. SchmittN, BustamanteJ, BourderyL, BentebibelSE, Boisson-DupuisS, et al. (2013) IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood 121: 3375–3385.
206. SchmittN, MoritaR, BourderyL, BentebibelSE, ZurawskiSM, et al. (2009) Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31: 158–169.
207. NakayamadaS, KannoY, TakahashiH, JankovicD, LuKT, et al. (2011) Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35: 919–931.
208. Ballesteros-TatoA, RandallTD (2014) Priming of T follicular helper cells by dendritic cells. Immunol Cell Biol 92: 22–27.
209. HaynesNM, AllenCD, LesleyR, AnselKM, KilleenN, et al. (2007) Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol 179: 5099–5108.
210. BaumjohannD, OkadaT, AnselKM (2011) Cutting edge: distinct waves of BCL6 expression during T follicular helper cell development. J Immunol 187: 2089–2092.
211. LiuYJ, JoshuaDE, WilliamsGT, SmithCA, GordonJ, et al. (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342: 929–931.
212. ChoeJ, KimHS, ZhangX, ArmitageRJ, ChoiYS (1996) Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. J Immunol 157: 1006–1016.
213. ZotosD, CoquetJM, ZhangY, LightA, D'CostaK, et al. (2010) IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 207: 365–378.
214. AruffoA, FarringtonM, HollenbaughD, LiX, MilatovichA, et al. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291–300.
215. OzakiK, SpolskiR, EttingerR, KimHP, WangG, et al. (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173: 5361–5371.
216. EttingerR, SimsGP, FairhurstAM, RobbinsR, da SilvaYS, et al. (2005) IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175: 7867–7879.
217. KuchenS, RobbinsR, SimsGP, ShengC, PhillipsTM, et al. (2007) Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 179: 5886–5896.
218. BryantVL, MaCS, AveryDT, LiY, GoodKL, et al. (2007) Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 179: 8180–8190.
219. DiSantoJP, BonnefoyJY, GauchatJF, FischerA, de Saint BasileG (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361: 541–543.
220. AllenRC, ArmitageRJ, ConleyME, RosenblattH, JenkinsNA, et al. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990–993.
221. QiH, CannonsJL, KlauschenF, SchwartzbergPL, GermainRN (2008) SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455: 764–769.
222. CannonsJL, QiH, LuKT, DuttaM, Gomez-RodriguezJ, et al. (2010) Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253–265.
223. YusufI, KageyamaR, MonticelliL, JohnstonRJ, DitoroD, et al. (2010) Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J Immunol 185: 190–202.
224. RezaeiN, MahmoudiE, AghamohammadiA, DasR, NicholsKE (2011) X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol 152: 13–30.
225. MohrsK, WakilAE, KilleenN, LocksleyRM, MohrsM (2005) A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity 23: 419–429.
226. ReinhardtRL, LiangH-E, LocksleyRM (2009) Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol 10: 385–393.
227. LuthjeK, KalliesA, ShimohakamadaY, GTTB, LightA, et al. (2012) The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol 13: 491–498.
228. LiuX, YanX, ZhongB, NurievaRI, WangA, et al. (2012) Bcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med 209: 1841–1824, 1841-1852, S1841-1824.
229. ZaretskyAG, TaylorJJ, KingIL, MarshallFA, MohrsM, et al. (2009) T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J Exp Med 206: 991–999.
230. FaheyLM, WilsonEB, ElsaesserH, FistonichCD, McGavernDB, et al. (2011) Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med 208: 987–999.
231. HirotaK, TurnerJE, VillaM, DuarteJH, DemengeotJ, et al. (2013) Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 14: 372–379.
232. SoghoianDZ, StreeckH (2010) Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines 9: 1453–1463.
233. SutoA, KashiwakumaD, KagamiS, HiroseK, WatanabeN, et al. (2008) Development and characterization of IL-21-producing CD4+ T cells. J Exp Med 205: 1369–1379.